Mission Wealth Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$574K Sell
8,220
-20
-0.2% -$1.4K 0.01% 420
2025
Q1
$606K Sell
8,240
-337
-4% -$24.8K 0.01% 387
2024
Q4
$562K Buy
8,577
+274
+3% +$18K 0.01% 385
2024
Q3
$647K Buy
8,303
+342
+4% +$26.6K 0.02% 365
2024
Q2
$621K Buy
7,961
+1,337
+20% +$104K 0.02% 345
2024
Q1
$449K Sell
6,624
-3,761
-36% -$255K 0.01% 438
2023
Q4
$699K Buy
10,385
+2,276
+28% +$153K 0.02% 289
2023
Q3
$549K Buy
8,109
+2,061
+34% +$140K 0.02% 308
2023
Q2
$433K Sell
6,048
-82
-1% -$5.87K 0.02% 360
2023
Q1
$425K Buy
6,130
+304
+5% +$21.1K 0.02% 355
2022
Q4
$395K Buy
5,826
+226
+4% +$15.3K 0.02% 356
2022
Q3
$307K Buy
5,600
+396
+8% +$21.7K 0.02% 375
2022
Q2
$344K Buy
5,204
+29
+0.6% +$1.92K 0.02% 359
2022
Q1
$343K Sell
5,175
-97
-2% -$6.43K 0.02% 368
2021
Q4
$307K Sell
5,272
-77
-1% -$4.48K 0.01% 408
2021
Q3
$321K Buy
5,349
+1,008
+23% +$60.5K 0.02% 376
2021
Q2
$260K Sell
4,341
-439
-9% -$26.3K 0.01% 415
2021
Q1
$238K Buy
4,780
+491
+11% +$24.4K 0.01% 403
2020
Q4
$214K Buy
4,289
+541
+14% +$27K 0.01% 393
2020
Q3
$205K Buy
+3,748
New +$205K 0.02% 341
2016
Q4
Sell
-6,994
Closed -$230K 176
2016
Q3
$230K Sell
6,994
-170
-2% -$5.59K 0.06% 146
2016
Q2
$216K Sell
7,164
-265
-4% -$7.99K 0.06% 142
2016
Q1
$209K Buy
7,429
+495
+7% +$13.9K 0.06% 142
2015
Q4
$235K Buy
6,934
+586
+9% +$19.9K 0.07% 118
2015
Q3
$202K Buy
+6,348
New +$202K 0.06% 128